Screening and Predictive Biomarkers for Down Syndrome Through Amniotic Fluid Metabolomics

Abstract excerpt

ABSTRACT Background Down syndrome (DS) is a congenital disorder caused by the presence of an extra copy of all or part of chromosome 21. It is characterized by significant intellectual disability, distinct facial features, and growth and developmental challenges. The utilization of metabolomics to analyze specific metabolic markers in maternal amniotic fluid may provide innovative tools and screening methods for...

Topics

Join the communities discussing this publication.

• Down syndrome and intellectual disability research
• Health, Environment, Cognitive Aging
• Prenatal Screening and Diagnostics